Future Science Group

In the Zone: phosphorylated biomarkers by Taylor & Francis Group

In this episode, we explore the often overlooked technique of environmental sequencing for infectious diseases and how it is being applied to the response to COVID-19. Taking the state of California and a case study of this application, I speak to Micheal Lisek, Project Manager Environmental Microbiomics at Zymo Research Corp. Micheal outlines the basis of environmental sequencing, predominantly t...

In this podcast, Tristan Free – Digital Editor at RegMedNet – speaks to Abbie Underhill (Scientific Bioprocessing) about the role that sensors have in regenerative medicine, including the biggest challenges behind implementing sensors in cell culture systems.

In Part 3 of our COVID-19 diagnostics and detection miniseries, supported by Roche, we explore the contribution PCR has made towards diagnosis during the pandemic. Providing me with an insight into the world of PCR diagnostics is Tyler Miller, Clinical Pathology Resident and Research Fellow at Massachusetts General Hospital, where he was instrumental in setting up the testing regimen for the Hospi...

Returning to the contentious topic of the Reproducibility crisis – the inability of many study results to be replicated by different research groups or labs – this episode, supported by Zymo Research, zeros in on the topic within the field of microbiomics. Speaking to me about the topic is Raul Cano, Chief Scientific Officer at the BioCollective. Raul discusses the crisis and explains wh...

Spotlight: precision medicine and companion diagnostics by Taylor & Francis Group

Virtual audits: limitations and future trends by Taylor & Francis Group

This International Women’s Day takeover episode, with special guest host BioTechniques’ Senior Digital Editor Abi Sawyer, takes a look at the results of Future Science Group’s (London, UK) survey for the scientific community on gender equality and parity in STEM. Abi’s guests on this episode are the Vice President of Epidemiology and Clinical Evidence at IQVIA (NC, USA), Dr Christina Mack; the Exe...

3DMedNet International Women's Day: an interview with Lee-Bath Nelson by Taylor & Francis Group

This episode takes a look at the role the COVID-19 Genomics UK Consortium (COG-UK) has played sequencing SARS-CoV-2 and surveying for COVID-19. To do this I speak to two key members of the consortium; Steve Paterson, Professor of genetics at the University of Liverpool and lead for the wastewater working group of COG-UK; and Josh Quick, Future Leaders Fellow at the University of Birmingham and lea...

In the Zone: how do we decide a vaccine is effective? by Taylor & Francis Group

RT-PCR, antigen and antibody testing; each has its niche and each has a flaw. But what are the key differences between each of these tests and when what are the key things to consider when selecting the appropriate COVID-19 diagnostic for you? In this podcast, supported by Zymo Research, I speak to Senior Scientist in assay development Paolo Piati in order to answer this question. Whether you are...

In this podcast, Juandem Agendia and Sarah Alexander (NCTC, UK) discuss bacteriophages, the function of the NCTC and the importance of depositing bacteriophages in the NCTC collection to improve accessibility and reproducibility in science.

OCTalks: Comprehensive Genomic Profiling by Taylor & Francis Group

OCTalks: the ethics of COVID-19 and cancer by Taylor & Francis Group

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma by Taylor & Francis Group

The importance of data management: an interview with Xiaonan Tang by Taylor & Francis Group

Brendan Griffin (University College Cork, Ireland)discusses his work in early drug development in this interview with Bioanalysis Zone. Brendan talks about the most common challenges faced as well as key trends in the field of developability. For more content, visit www.bioanalysis-zone.com

In this Technique Blast – a new series that will provide short informative discussions about a specific technique – Digital Editor Tristan Free speaks to Joseph Pesek about high-performance liquid-chromatography and chromatographic separation technologies.

In the face of the COVID-19 pandemic, innovators are finding novel ways to apply 3D-printed solutions to assist the international response to coronavirus. From meeting PPE demands, to designing novel approaches to unique challenges, the additive community has not been short of opportunity for collaboration and corroboration with multidisciplinary teams exploring options for aiding crises from loca...

Integrating patient-relevant outcomes into clinical practice: an interview with Donna Messner by Taylor & Francis Group

NCTalks with Gavin Giovannoni: advancements in the treatment landscape for multiple sclerosis by Taylor & Francis Group

Comparing real-world and randomized controlled trial data: an interview with Michael Moran by Taylor & Francis Group

BioTechniques Digital Editor Tristan Free, speaks to Application Scientist Theresa Thompson and Strategy Director Jay Pasquantonio (both Phoseon Technology) about their UV LEDs. We cover the best wavelengths for disrupting nucleotides and proteins, the challenges associated with some of these wavelengths, and the promising potential of UV LEDs to disinfect inorganic surfaces of SARS-CoV-2. Theresa...

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion by Taylor & Francis Group